Steven Sloshberg

Title: Innovations of Steven Sloshberg in Hemoglobin Compositions

Introduction

Steven Sloshberg is an accomplished inventor based in Union, NJ (US). He has made significant contributions to the field of hemoglobin compositions, holding a total of three patents. His work focuses on the development of PEGylated hemoglobin, which has important applications in medical treatments.

Latest Patents

One of Steven Sloshberg's latest patents involves hemoglobin compositions that contain PEGylated hemoglobin. This innovative molecule is capable of transferring oxygen or carbon monoxide to nearby tissues. The formulations are designed to be virally inactivated, ensuring safety in medical applications. The compositions may include deoxygenated hemoglobin, which can be conjugated with water-soluble polymers. Notably, the PEGylated hemoglobin can exist in forms where the iron atom is not bound to oxygen or other species, allowing for versatility in treatment options. These compositions are formulated as hypo-, iso-, or hypertonic solutions, making them useful for treating various diseases and injuries by enhancing tissue oxygenation.

Career Highlights

Steven Sloshberg is currently associated with Prolong Pharmaceuticals, LLC, where he continues to innovate in the field of hemoglobin research. His work has the potential to significantly impact medical treatments and improve patient outcomes.

Collaborations

Throughout his career, Steven has collaborated with notable professionals in the field, including Abraham Abuchowski and Keith O'Hare. These collaborations have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Steven Sloshberg's contributions to hemoglobin compositions exemplify the importance of innovation in medical science. His work not only enhances our understanding of hemoglobin but also paves the way for new treatment options that can improve health outcomes.